Tag: M.W:200-300

SDS of cas: 2407-11-6. Aromatic heterocyclic compounds can also be classified according to the number of heteroatoms contained in the heterocycle: single heteroatom, two heteroatoms, three heteroatoms and four heteroatoms. Compound: 2-Chloro-6-nitrobenzo[d]thiazole, is researched, Molecular C7H3ClN2O2S, CAS is 2407-11-6, about HFIP promoted thio(hetero)arylation of imidazoheterocycles under metal- and base-free conditions. Author is Chaubey, Narendra R.; Kapdi, Anant R..

A new reaction methodol. has been developed for HFIP promoted Thio(hetero)arylation of imidazoheterocycles I (R = H, 4-Me, 4-CN, 3-Br, etc.) under metal and base-free conditions. This is the first report that describes linking of imidazopyridines I with electron deficient heteroarenes R1Cl (R1 = 2-benzothiazolyl, 2-pyrazinyl, 2-quinoxalinyl, 3-fluoro-2-pyridinyl, etc.) through a sulfur atom and also for the synthesis of most of these compds II. The reaction conditions are well tolerated by almost all kinds of 2-chloroheteroarenes and a wide range of imidazoheterocycles I. The synthesized compounds II can show significant biol. properties.

There is still a lot of research devoted to this compound(SMILES：O=[N+](C1=CC=C2N=C(Cl)SC2=C1)[O-])SDS of cas: 2407-11-6, and with the development of science, more effects of this compound(2407-11-6) can be discovered.

Reference:
Highly efficient and robust molecular ruthenium catalysts for water oxidation,
Catalysts | Special Issue : Ruthenium Catalysts – MDPI

In organic chemistry, atoms other than carbon and hydrogen are generally referred to as heteroatoms. The most common heteroatoms are nitrogen, oxygen and sulfur. Now I present to you an article called Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors, published in 2016-08-25, which mentions a compound: 2407-11-6, mainly applied to imidazoquinoline derivative preparation cancer osaka thyroid kinase inhibitor antiinflammatory, Recommanded Product: 2407-11-6.

Cancer Osaka thyroid (COT) kinase is an important regulator of pro-inflammatory cytokines in macrophages. Thus, pharmacol. inhibition of COT should be a valid approach to therapeutically intervene in the pathogenesis of macrophage-driven inflammatory diseases such as rheumatoid arthritis. We report the discovery and chem. optimization of a novel series of COT kinase inhibitors, with unprecedented nanomolar potency for the inhibition of TNFα. Pharmacol. profiling in vivo revealed a high metabolism of these compounds in rats which was demonstrated to be predominantly attributed to aldehyde oxidase. Due to the very low activity of hepatic AO in the dog, the selected candidate 32 displayed significant blood exposure in dogs which resulted in a clear prevention of inflammation-driven lameness. Taken together, the described compounds both potently and selectively inhibit COT kinase in primary human cells and ameliorate inflammatory pathologies in vivo, supporting the notion that COT is an appropriate therapeutic target for inflammatory diseases.

There is still a lot of research devoted to this compound(SMILES：O=[N+](C1=CC=C2N=C(Cl)SC2=C1)[O-])Recommanded Product: 2407-11-6, and with the development of science, more effects of this compound(2407-11-6) can be discovered.

Reference:
Highly efficient and robust molecular ruthenium catalysts for water oxidation,
Catalysts | Special Issue : Ruthenium Catalysts – MDPI

Heterocyclic compounds can be divided into two categories: alicyclic heterocycles and aromatic heterocycles. Compounds whose heterocycles in the molecular skeleton cannot reflect aromaticity are called alicyclic heterocyclic compounds. Compound: 2407-11-6, is researched, Molecular C7H3ClN2O2S, about Benzothiazole derivatives. VII. Synthesis of some N-(2-benzothiazolyl)anthranilic acids as potential antiinflammatory agents, the main research direction is anthranilate benzothiazolyl antiinflammatory; benzothiazolylanthranilate antiinflammatory; benzothiazoloquinolinone cleavage.Name: 2-Chloro-6-nitrobenzo[d]thiazole.

The benzothiazoles I (R = H, Cl, NO2) were cyclized with 2,4,5-H2NR1R2C6H2CO2H (R1 = H, Cl, Br; R2 = H, Br) to give the benzothiazoloquinazolinones II, which were cleaved with KOH to give the title compounds III. At 60 mg/kg III (R = R2 = H, R1 = Br) inhibited carrageenin induced rat paw edema by 68%.

There is still a lot of research devoted to this compound(SMILES：O=[N+](C1=CC=C2N=C(Cl)SC2=C1)[O-])Name: 2-Chloro-6-nitrobenzo[d]thiazole, and with the development of science, more effects of this compound(2407-11-6) can be discovered.

Reference:
Highly efficient and robust molecular ruthenium catalysts for water oxidation,
Catalysts | Special Issue : Ruthenium Catalysts – MDPI

SDS of cas: 2407-11-6. Aromatic heterocyclic compounds can also be classified according to the number of heteroatoms contained in the heterocycle: single heteroatom, two heteroatoms, three heteroatoms and four heteroatoms. Compound: 2-Chloro-6-nitrobenzo[d]thiazole, is researched, Molecular C7H3ClN2O2S, CAS is 2407-11-6, about Structure-activity relationships of benzothiazole GPR35 antagonists. Author is Abdalhameed, Manahil M.; Zhao, Pingwei; Hurst, Dow P.; Reggio, Patricia H.; Abood, Mary E.; Croatt, Mitchell P..

The first structure-activity relationships for a benzothiazole scaffold acting as an antagonist at GPR35 is presented. Analogs were designed based on a lead compound that was previously determined to have selective activity as a GPR35 antagonist. The synthetic route was modular in nature to independently explore the role of the middle and both ends of the scaffold. The activities of the analogs illustrate the importance of all three segments of the compound

There is still a lot of research devoted to this compound(SMILES：O=[N+](C1=CC=C2N=C(Cl)SC2=C1)[O-])SDS of cas: 2407-11-6, and with the development of science, more effects of this compound(2407-11-6) can be discovered.

Reference:
Highly efficient and robust molecular ruthenium catalysts for water oxidation,
Catalysts | Special Issue : Ruthenium Catalysts – MDPI

The chemical properties of alicyclic heterocycles are similar to those of the corresponding chain compounds. Compound: 2-Chloro-6-nitrobenzo[d]thiazole, is researched, Molecular C7H3ClN2O2S, CAS is 2407-11-6, about Triazolbenzo[d]thiazoles: efficient synthesis and biological evaluation as neuroprotective agents, the main research direction is triazolbenzothiazole derivative preparation click chem neuroprotective agent.Recommanded Product: 2-Chloro-6-nitrobenzo[d]thiazole.

A series of (1H-1,2,3-triazol-1-yl)benzo[d]thiazoles were synthesized utilizing a versatile Cu-catalyzed azide-alkyne click reaction (CuAAC) on tautomeric benzo[4,5]thiazolo[3,2-d]tetrazole and 2-azidobenzo[d]thiazole starting materials. Moreover, compound I, was found to possess significant neuroprotective activity in human neuroblastoma (SH-SY5Y) cells.

There is still a lot of research devoted to this compound(SMILES：O=[N+](C1=CC=C2N=C(Cl)SC2=C1)[O-])Recommanded Product: 2-Chloro-6-nitrobenzo[d]thiazole, and with the development of science, more effects of this compound(2407-11-6) can be discovered.

Reference:
Highly efficient and robust molecular ruthenium catalysts for water oxidation,
Catalysts | Special Issue : Ruthenium Catalysts – MDPI

Formula: C7H3ClN2O2S. Aromatic heterocyclic compounds can also be classified according to the number of heteroatoms contained in the heterocycle: single heteroatom, two heteroatoms, three heteroatoms and four heteroatoms. Compound: 2-Chloro-6-nitrobenzo[d]thiazole, is researched, Molecular C7H3ClN2O2S, CAS is 2407-11-6, about Luciferin Derivatives for Enhanced in Vitro and in Vivo Bioluminescence Assays. Author is Shinde, Rajesh; Perkins, Julie; Contag, Christopher H..

In vivo bioluminescence imaging has become a cornerstone technol. for preclin. mol. imaging. This imaging method is based on light-emitting enzymes, luciferases, which require specific substrates for light production When linked to a specific biol. process in an animal model of human biol. or disease, the enzyme-substrate interactions become biol. indicators that can be studied noninvasively in living animals. Signal intensity in these animal models depends on the availability of the substrate for the reaction within living cells in intact organs. The biodistribution and clearance rates of the substrates are therefore directly related to optimal imaging times and signal intensities and ultimately determine the sensitivity of detection and predictability of the model. Modifications of D-luciferin, the substrate for the luciferases obtained from beetle, including fireflies, result in novel properties and offer opportunities for improved bioassays. For this purpose, the authors have synthesized a conjugate, glycine-D-aminoluciferin, and investigated its properties relative to those of D-aminoluciferin and D-luciferin. The three substrates exhibited different kinetic properties and different intracellular accumulation profiles due to differences in their mol. structure, which in turn influenced their biodistribution in animals. Glycine-D-aminoluciferin had a longer in vivo circulation time than the other two substrates. The ability to assay luciferase in vitro and in vivo using these substrates, which exhibit different pharmacokinetic and pharmacodynamic properties, will provide flexibility and improve current imaging capabilities.

There is still a lot of research devoted to this compound(SMILES：O=[N+](C1=CC=C2N=C(Cl)SC2=C1)[O-])Formula: C7H3ClN2O2S, and with the development of science, more effects of this compound(2407-11-6) can be discovered.

Reference:
Highly efficient and robust molecular ruthenium catalysts for water oxidation,
Catalysts | Special Issue : Ruthenium Catalysts – MDPI

The three-dimensional configuration of the ester heterocycle is basically the same as that of the carbocycle. Compound: 2-Chloro-6-nitrobenzo[d]thiazole(SMILESS: O=[N+](C1=CC=C2N=C(Cl)SC2=C1)[O-],cas:2407-11-6) is researched.HPLC of Formula: 148-51-6. The article 《Bioorthogonal Catalysis: A General Method To Evaluate Metal-Catalyzed Reactions in Real Time in Living Systems Using a Cellular Luciferase Reporter System》 in relation to this compound, is published in Bioconjugate Chemistry. Let’s take a look at the latest research on this compound (cas:2407-11-6).

The development of abiol. catalysts that can function in biol. systems is an emerging subject of importance with significant ramifications in synthetic chem. and the life sciences. Herein we report a biocompatible ruthenium complex [Cp(MQA)Ru(C3H5)]+PF6-2 (Cp = cyclopentadienyl, MQA = 4-methoxyquinoline-2-carboxylate) and a general anal. method for evaluating its performance in real time based on a luciferase reporter system amenable to high throughput screening in cells and by extension to evaluation in luciferase transgenic animals. Precatalyst 2 activates alloc-protected aminoluciferin 4b, a bioluminescence pro-probe, and releases the active luminophore, aminoluciferin (4a), in the presence of luciferase-transfected cells. The formation and enzymic turnover of 4a, an overall process selected because it emulates pro-drug activation and drug turnover by an intracellular target, is evaluated in real time by photon counting as 4a is converted by intracellular luciferase to oxyaminoluciferin and light. Interestingly, while the catalytic conversion (activation) of 4b to 4a in water produces multiple products, the presence of biol. nucleophiles such as thiols prevents byproduct formation and provides almost exclusively luminophore 4a. Our studies show that precatalyst 2 activates 4b extracellularly, exhibits low toxicity at concentrations relevant to catalysis, and is comparably effective in two different cell lines. This proof of concept study shows that precatalyst 2 is a promising lead for bioorthogonal catalytic activation of pro-probes and, by analogy, similarly activatable pro-drugs. More generally, this study provides an anal. method to measure abiol. catalytic activation of pro-probes and, by analogy with our earlier studies on pro-Taxol, similarly activatable pro-drugs in real time using a coupled biol. catalyst that mediates a bioluminescent readout, providing tools for the study of imaging signal amplification and of targeted therapy.

There is still a lot of research devoted to this compound(SMILES：O=[N+](C1=CC=C2N=C(Cl)SC2=C1)[O-])Product Details of 2407-11-6, and with the development of science, more effects of this compound(2407-11-6) can be discovered.

Reference:
Highly efficient and robust molecular ruthenium catalysts for water oxidation,
Catalysts | Special Issue : Ruthenium Catalysts – MDPI

So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic.Gallagher, Peter T.; Iddon, Brian; Suschitzky, Hans researched the compound: 2-Chloro-6-nitrobenzo[d]thiazole( cas:2407-11-6 ).HPLC of Formula: 2407-11-6.They published the article 《Synthesis and reactions of azidobenzothiazoles and -benzo[b]thiophenes. Novel thiazolo[4,5-g]benzoxazoles and dihydrothieno[3,2-g]benzoxazoles》 about this compound( cas:2407-11-6 ) in Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999). Keywords: azidobenzothiazole thermolysis thiazolobenzoxazole; azidodihydrobenzothiophene dioxide thermolysis dihydromethylthienobenzoxazole; hydromethylthienobenzoxazole dioxide; thienobenzoxazole dioxide dihydro methyl; fluoronitrobenzothiazole; chloronitrobenzothiazole fluoride substitution; nitrobenzothiazole fluoro; benzothiazole nitro fluoro. We’ll tell you more about this compound (cas:2407-11-6).

6-Azidobenzothiazole and its 2-Me and 2-(methylthio) derivatives, prepared from the corresponding amines by diazotization and reaction with NaN3, gave the thiazolo[4,5-g]benzoxazoles I (R = H, Me, SH) (50, 42 and 20%, resp.) on thermolysis (120°, 1.5 h) in a polyphosphoric acid-HOAc mixture Under similar conditions 6-azido-2,3-dihydrobenzo[b]thiophene 1,1-dioxide gave 11% II. 2-Fluoro-6-nitrobenzothiazole was prepared in almost quant. yield by reaction of the chloro analog with F- in MeCN containing 18-crown-6.

There is still a lot of research devoted to this compound(SMILES：O=[N+](C1=CC=C2N=C(Cl)SC2=C1)[O-])HPLC of Formula: 2407-11-6, and with the development of science, more effects of this compound(2407-11-6) can be discovered.

Reference:
Highly efficient and robust molecular ruthenium catalysts for water oxidation,
Catalysts | Special Issue : Ruthenium Catalysts – MDPI

Application of 2407-11-6. So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic. Compound: 2-Chloro-6-nitrobenzo[d]thiazole, is researched, Molecular C7H3ClN2O2S, CAS is 2407-11-6, about Acylotropic tautomerism. XXII. Structure of the heterocyclic ring and kinetics of heterylotropic rearrangement in a series of O-derivatives of 3,5,7-trimethyltropolone.

Rate constants and activation parameters were determined for the migration of heteroaromatic fragments (R) between the O atoms in tropolones I. The reactivity decreased in the following order of R: dichloro-s-triazin-2-yl ≫ 3,5-dinitro-2-pyridyl > 5-nitro-2-pyrimidinyl > 3-cyano-5-nitro-2-pyridyl > 5-cyano-4-pyrimidinyl > 6-nitro-2-benzothiazolyl.

In some applications, this compound(2407-11-6)Application of 2407-11-6 is unique.If you want to know more details about this compound, you can contact with the author or consult more relevant literature.

Reference:
Highly efficient and robust molecular ruthenium catalysts for water oxidation,
Catalysts | Special Issue : Ruthenium Catalysts – MDPI

The chemical properties of alicyclic heterocycles are similar to those of the corresponding chain compounds. Compound: 2-Chloro-6-nitrobenzo[d]thiazole, is researched, Molecular C7H3ClN2O2S, CAS is 2407-11-6, about Tacrine-Benzothiazoles: Novel class of potential multitarget anti-Alzheimers drugs dealing with cholinergic, amyloid and mitochondrial systems, the main research direction is design synthesis evaluation tacrine benzothiazole compound; tacrine benzothiazole multitarget anti Alzheimers drug; ABAD; Acetylcholinesterase Inhibitors; Alzheimer’s disease; Amyloid β; Benzothiazole; MTDLs; Tacrine.Electric Literature of C7H3ClN2O2S.

A series of tacrine – benzothiazole hybrids incorporate inhibitors of acetylcholinesterase (AChE), amyloid β (Aβ) aggregation and mitochondrial enzyme ABAD, whose interaction with Aβ leads to mitochondrial dysfunction, into a single mol. In vitro, several of 25 final compounds exerted excellent anti-AChE properties and interesting capabilities to block Aβ aggregation. The best derivative of the series could be considered I that was found to be highly potent and selective towards AChE with the IC50 value in nanomolar range. Moreover, the same drug candidate exerted absolutely the best results of the series against ABAD, decreasing its activity by 23% at 100μM concentration Regarding the cytotoxicity profile of highlighted compound, it roughly matched that of its parent compound 6-chlorotacrine. Finally, I was forwarded for in vivo scopolamine-induced amnesia experiment consisting of Morris Water Maze test, where it demonstrated mild precognitive effect. Taking into account all in vitro and in vivo data, highlighted derivative I could be considered as the lead structure worthy of further investigation.

In some applications, this compound(2407-11-6)Electric Literature of C7H3ClN2O2S is unique.If you want to know more details about this compound, you can contact with the author or consult more relevant literature.

Reference:
Highly efficient and robust molecular ruthenium catalysts for water oxidation,
Catalysts | Special Issue : Ruthenium Catalysts – MDPI